Cicero IL 非小细胞肺癌临床试验
24项针对 非小细胞肺癌的研究正在 Cicero及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本（英文）
正在为研究招募参与者？将此页面置顶展示 — $99 / 30天 →
Study to Evaluate Adverse Events and Efficacy of Intravenous (IV) Telisotuzumab Adizutecan in Combination With a PD-1 Immune Checkpoint Inhibitor in Adult Participants With Advanced or Metastatic Non-Squamous NSCLC With No Prior Treatment for Advanced Disease, and No Actionable Genomic Alterations
招募中1/2 期
- Hope And Healing Cancer Services /ID# 276223, Hinsdale · 距离 10 英里
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
招募中3 期
- Edward Hines Jr VA Hospital, Hines · 距离 4 英里
- Advocate Christ Medical Center, Oak Lawn · 距离 9 英里
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
招募中3 期
- Northwestern Medicine Oak Brook, Oak Brook · 距离 9 英里
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
招募中3 期
- Hope and Healing Cancer Services, Hinsdale · 距离 10 英里
This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.
招募中3 期
- Advocate Christ Medical Center, Oak Lawn · 距离 9 英里
- Hope and Healing Cancer Services, Hinsdale · 距离 10 英里
- Endeavor Health, Elmhurst · 距离 10 英里
Symbiotic-Lung-10: A Study to Learn About PF-08634404 Alone or in Combination in Early-stage or Locally Advanced NSCLC
招募中2 期
- Hope and Healing Clinical Research, Hinsdale · 距离 10 英里
Phase III, Open-label, Study of First-line Dato-DXd in Combination With Rilvegostomig for Advanced Non-squamous NSCLC With High PD-L1 Expression (TC ≥ 50%) and Without Actionable Genomic Alterations
招募中3 期
- Research Site, Hinsdale · 距离 10 英里
A Study to Compare the Efficacy of Nivolumab and Relatlimab Plus Chemotherapy vs Pembrolizumab Plus Chemotherapy for Stage IV/Recurrent Non-squamous Non-small Cell Lung Cancer With PD-L1 Expression ≥ 1%
招募中3 期
- Affiliated Oncologists, LLC, Chicago Ridge · 距离 10 英里
A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)
招募中3 期
- Research Site, Hinsdale · 距离 10 英里
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
招募中2/3 期
- Loyola University Medical Center, Maywood · 距离 5 英里
Study of Trastuzumab Deruxtecan, Pembrolizumab, and Platinum-based Chemotherapy in First-line HER2 Overexpressing Non-small Cell Lung Cancer
招募中3 期
- Hope and Healing Cancer Services, Hinsdale · 距离 10 英里
A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
招募中3 期
- Affiliated Oncologists, LLC, Chicago Ridge · 距离 10 英里
Phase III Study of Datopotamab Deruxtecan Versus Docetaxel in Previously Treated TROP2-positive Advanced or Metastatic Non-squamous NSCLC Without Actionable Genomic Alterations
招募中3 期
- Research Site, Hinsdale · 距离 10 英里
Phase III, Open-label Study of First-line Osimertinib With or Without Datopotamab Deruxtecan for EGFRm Locally Advanced or Metastatic Non-small Cell Lung Cancer
招募中3 期
- Research Site, Hinsdale · 距离 10 英里
Radiotherapy to Block Oligoprogression In Metastatic Non-Small-Cell Lung Cancer
招募中3 期
- Northwestern Medicine Oak Brook, Oak Brook · 距离 9 英里
LUNAR-2: TTFields With Pembrolizumab + Platinum-based Chemotherapy for Metastatic NSCLC
招募中3 期
- Elmhurst Hospital Nancy Knowles Cancer Center, Elmhurst · 距离 10 英里
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
招募中2 期
- Rush MD Anderson Cancer Center at Rush Oak Park, Oak Park · 距离 3 英里
- Edward Hines Jr VA Hospital, Hines · 距离 4 英里
- Loyola University Medical Center, Maywood · 距离 5 英里
- 以及另外 2 项
MYLUNG Consortium Part 3: Observational Study
招募中观察性研究
- Affiliated Oncologists, LLC, Chicago Ridge · 距离 10 英里
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of the MET Gene (An Expanded Lung-MAP Treatment Trial)
招募中2 期
- Edward Hines Jr VA Hospital, Hines · 距离 4 英里
- Loyola University Medical Center, Maywood · 距离 5 英里
- Northwestern Medicine Oak Brook, Oak Brook · 距离 9 英里
- 以及另外 3 项
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
招募中2/3 期
- Loyola University Medical Center, Maywood · 距离 5 英里
- Northwestern Medicine Oak Brook, Oak Brook · 距离 9 英里
- Advocate Christ Medical Center, Oak Lawn · 距离 9 英里
- 以及另外 2 项
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
招募中2 期
- Edward Hines Jr VA Hospital, Hines · 距离 4 英里
- Loyola University Medical Center, Maywood · 距离 5 英里
- Northwestern Medicine Oak Brook, Oak Brook · 距离 9 英里
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
招募中观察性研究
- Advocate Christ Medical Center, Oak Lawn · 距离 9 英里
- Advocate Outpatient Center - Oak Lawn, Oak Lawn · 距离 9 英里
- Advocate High Tech Medical Park, Palos Heights · 距离 12 英里
Veterans Affairs Lung Cancer Surgery Or Stereotactic Radiotherapy
招募中
- Edward Hines Jr. VA Hospital, Hines, IL, Hines · 距离 4 英里
GEMINI-NSCLC: NSCLC Biomarker Study
招募中观察性研究
- Hope and Healing Cancer Services, Hinsdale · 距离 10 英里
其他城市的 非小细胞肺癌试验
- Houston, TX145 项研究
- New York City, NY121 项研究
- Arlington, VA104 项研究
- Nashville, TN97 项研究
- Boston, MA90 项研究
- Los Angeles, CA87 项研究
- St. Louis, MO73 项研究
- Chicago, IL61 项研究
- Baltimore, MD60 项研究
- San Antonio, TX59 项研究
- Columbus, OH57 项研究
- Washington, DC55 项研究
Cicero的其他研究
- 肺癌17 项研究
- 前列腺癌14 项研究
- 癌症（所有类型）13 项研究
- 乳腺癌11 项研究
- 急性髓系白血病11 项研究
- 结直肠癌10 项研究
- 膀胱癌8 项研究
- 黑色素瘤7 项研究
- 心血管疾病7 项研究
- 转移性癌症7 项研究
- 多发性骨髓瘤6 项研究
- 伯基特淋巴瘤6 项研究
数据来自 ClinicalTrials.gov，检索日期：2026年10月6日。每项研究自行设定入选标准，由研究团队决定谁能参与。